MAKO Surgical (MAKO.DL) is the surgical-robot company that many thought might become the next Intuitive Surgical (ISRG -0.83%). However, two terrible quarters to start the year hammered shares price and investor confidence. In this video, Motley Fool health-care analyst David Williamson tells us what the upside for MAKO might be and whether he thinks the short-sellers are right.
Are the Shorts Wrong About MAKO?
By Dave Williamson
-
Dec 11, 2012 at 6:30PM
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
NASDAQ: MAKO.DL
MAKO Surgical Corp.

MAKO Surgical is the sixth most short-sold health-care stock on the market.
Stocks Mentioned

MAKO Surgical Corp.
MAKO.DL

General Electric Company
GE
$66.71
(-0.43%)
$0.29

Intuitive Surgical, Inc.
ISRG
$207.94
(-0.83%)
$-1.73

Hansen Medical, Inc.
HNSN
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
Why Do You Still Own MAKO Surgical?
What Medtronic Needs to Beat the Stryker-MAKO Merger
MAKO Surgical Q3 Revenues Drop, Net Loss Deepens
Does the Robotic Surgery Industry Need Obamacare to Succeed?
So You Sold MAKO Surgical: Now What?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.